We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+7.75%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$19.9B
AUM Growth
+$1.62B
Cap. Flow
-$35.6M
Cap. Flow %
-0.18%
Top 10 Hldgs %
43.73%
Holding
208
New
17
Increased
41
Reduced
35
Closed
35

Sector Composition

Rank Sector Weight
1 Healthcare 35.32%
2 Technology 16.45%
3 Financials 12.17%
4 Industrials 7.23%
5 Communication Services 3.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVCP
101
DELISTED
Swiftmerge Acquisition Corp. Class A Ordinary Share
IVCP
$3.1M 0.02%
300,000
-1,680,000
-85% -$17.4M
BACA
102
DELISTED
Berenson Acquisition Corp. I
BACA
$2.93M 0.01%
285,715
-2,189,285
-88% -$22.3M
ATTO
103
DELISTED
Atento S.A.
ATTO
$2.23M 0.01%
2,230,357
ARYD
104
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$2.13M 0.01%
200,000
PRVA icon
105
Privia Health
PRVA
$2.87B
$1.93M 0.01%
+74,000
New +$1.95M
GATE
106
DELISTED
Marblegate Acquisition Corp. Class A Common Stock
GATE
$1.56M 0.01%
150,000
ICE icon
107
Intercontinental Exchange
ICE
$84.4B
$1.45M 0.01%
12,786
-39,046
-75% -$4.23M
BPMC
108
DELISTED
Blueprint Medicines
BPMC
$1.42M 0.01%
22,420
MTAL.WS
109
DELISTED
Metals Acquisition Limited Warrants to purchase one share of Ordinary Share, each at an exercise price of $11.50 per share
MTAL.WS
$1.16M 0.01%
825,000
OKLO
110
Oklo
OKLO
$8.42B
$1.03M 0.01%
98,300
SMC
111
Summit Midstream
SMC
$419M
$946K ﹤0.01%
58,214
TECX
112
Tectonic Therapeutic
TECX
$606M
$855K ﹤0.01%
74,975
-184,692
-71% -$2.09M
MDGL icon
113
Madrigal Pharmaceuticals
MDGL
$11.8B
$767K ﹤0.01%
3,319
-160,500
-98% -$43.5M
CYTK icon
114
Cytokinetics
CYTK
$10.4B
$710K ﹤0.01%
21,772
-916,300
-98% -$33.9M
EDU icon
115
New Oriental
EDU
$8.98B
$513K ﹤0.01%
13,000
KRTX
116
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$477K ﹤0.01%
2,200
LUNRW
117
DELISTED
Intuitive Machines, Inc. Warrants
LUNRW
$462K ﹤0.01%
950,000
BNTX icon
118
BioNTech
BNTX
$23.5B
$415K ﹤0.01%
3,844
-133,800
-97% -$15M
ALNY icon
119
Alnylam Pharmaceuticals
ALNY
$29.3B
$380K ﹤0.01%
2,000
-4,719
-70% -$936K
GRND.WS
120
DELISTED
Grindr Inc. Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
GRND.WS
$378K ﹤0.01%
540,000
BTTX
121
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
$357K ﹤0.01%
330,619
-368,423
-53% -$356K
CLVR
122
DELISTED
Clever Leaves Holdings Inc. Common Shares
CLVR
$330K ﹤0.01%
54,312
-9,953
-15% -$81.1K
ARWR icon
123
Arrowhead Research
ARWR
$12.4B
$207K ﹤0.01%
+5,800
New +$200K
IONS icon
124
Ionis Pharmaceuticals
IONS
$9.4B
$205K ﹤0.01%
+5,000
New +$192K
AAC.WS
125
DELISTED
Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AAC.WS
$160K ﹤0.01%
200,000

Similar funds

Farallon Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Farallon Capital Management held 208 positions worth $19.9B, up 8.8% from $18.3B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Farallon Capital Management's Q2 2023 filing shows 17 new, 41 increased, 35 reduced and 35 closed positions. Its largest new stake was Analog Devices: 2,075,000 shares worth $404M. The largest sale was Shaw Communications Inc., an estimated $473M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Technology and Financials.

  • Farallon Capital Management's largest Q2 2023 buy was Analog Devices: 2,075,000 shares worth $404M.
  • Farallon Capital Management added most to VMware, Inc in Q2 2023, an estimated $286M increase.
  • Farallon Capital Management's biggest Q2 2023 reduction was Salesforce, cutting an estimated $318M.
  • Farallon Capital Management fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $473M.
  • Farallon Capital Management's ten largest holdings make up 44% of its $19.9B portfolio in Q2 2023.
  • Farallon Capital Management opened 17 new positions and closed 35 in Q2 2023.
  • Farallon Capital Management's portfolio value rose 8.8% quarter-over-quarter to $19.9B.

Based on Farallon Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.